RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a level ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...

Goodell, an expert in the field of stem cell research, has been elected as one of the newest members of the National ...

Leveraging whole slide embedding from pretrained foundation models (FMs) improves nonmelanoma skin cancer (NMSC) diagnosis, ...

Throughout the Middle East and beyond, health care institutions rely on robotic-assisted surgery, AI-powered diagnostics and ...

Goodell, an expert in the field of stem cell research, has been elected as one of the newest members of the National Academy ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and neck squamous cell carcinoma.

In their research, scientists have identified a change in gene expression in the placenta of pregnant women with cancer. The ...

Bristol Myers Squibb (BMS), a leading biopharmaceutical company with a dominant position in immuno-oncology, held a press conference in Cyprus on April 29, 2025, where eminent pathologists-oncologists ...

Willow Biosciences Inc. (the "Company") announces the completion today of the sale (the "Transaction") of its wholly-owned ...

According to the latest study from BCC Research, the "Global Fluorescence Microscopy Market" is expected to grow from $968.5 million in 2024 to $1.3 billion by the end of 2029, at a compound annual ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.